Anti-Angiotensin-Receptor 1 (ATR1)-, Anti-Endothelin-Receptor A (ETRA)-Antibodies and T Cells in Cardiomyopathy
CompletedOBSERVATIONAL
Enrollment
80
Participants
Timeline
Start Date
December 31, 2014
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2020
Conditions
Cardiac Failure
Trial Locations (1)
CH-8620
GZO Regional Health Center, Wetzikon
All Listed Sponsors
lead
Zurich Regional Health Center
OTHER
NCT02319590 - Anti-Angiotensin-Receptor 1 (ATR1)-, Anti-Endothelin-Receptor A (ETRA)-Antibodies and T Cells in Cardiomyopathy | Biotech Hunter | Biotech Hunter